Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

Clinical trials of novel therapeutics for Alzheimer’s Disease (AD) have consumed a significant amount of time and resources with largely negative results. Repurposing drugs already approved by the Food and Drug Administration (FDA), European Medicines Agency (EMA), or Worldwide for another indicatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Shityakov, Sergey, Skorb, Ekaterina V., Förster, Carola Y., Dandekar, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571023/
https://www.ncbi.nlm.nih.gov/pubmed/34751244
http://dx.doi.org/10.3389/fchem.2021.736509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571023/
https://www.ncbi.nlm.nih.gov/pubmed/34751244
http://dx.doi.org/10.3389/fchem.2021.736509

Ejemplares similares